Press Release: Private Equity - Venture Capital (PE-VC) firms invested over $6.2 Billion (across 205 deals) in Indian companies during the first three months of 2024, shows data from Venture Intelligence , a research service focused on private company financials, transactions, and their valuations. (Note: These figures include Venture Capital type investments, but exclude PE investments in Real Estate). The investment amount represents a 8% fall over the $6.7 Billion (across 242 deals) invested in the same period during 2023 and also down by 6% when compared to the immediate previous quarter (which witnessed $6.6 Billion being invested across 200 deals). Deal volumes in Q1'24 also declined 15% compared to Q1'23 and were up by 3% compared to the immediate previous quarter. Q1’24 witnessed 8 mega deals ($100 M+ rounds) worth $3.5 Billion, compared to 17 such investments (worth $3.6 Billion) in Q1’23 and 15 such deals (worth $4.1 Billion) in the immediate previous quarter. Th
Cyril Amarchand Mangaldas and AZB & Partners claim the No.2 & No.3 slots Shardul Amarchand Mangaldas (SAM) topped the Venture Intelligence League Table for Legal Advisor to M&A Transactions by value during 2023. SAM advised 54 M&A deals worth $12.3 Billion, followed by Cyril Amarchand Mangaldas (CAM) with $12.27 Billion across 81 deals and AZB & Partners ($10.9 Billion across 63 deals). Trilegal ($9.3 Billion across 63 deals) took the fourth spot with Khaitan & Co. ($6.6 Billion across 97 deals) completing the top five Among the largest M&A deals during 2023, Trilegal, JSA, AZB, SAM and Milbank advised the $2 Billion investment in Manipal Hospitals by Temasek (which gained majority control). Saraf Partners advised the $1.2 Billion divestment of Viatris’ India twin business to Insud Pharma and IQuest Enterprise . AZB, Wadia Ghandy, J Sagar Associates (JSA) and SAM advised the $1.1 Billion buyout of HDFC Credila by consortium of private equity firms,